CD24 and neoplasm: The loss of CD24a was associated with delayed tumor growth and a shift in the TME toward a more immunologically active state, characterized by enhanced anti-tumor activity of macrophages, and cytotoxic CD8+ T cells, along with reduced gMDSCs accumulation.